CO2020016080A2 - Compuestos - Google Patents

Compuestos

Info

Publication number
CO2020016080A2
CO2020016080A2 CONC2020/0016080A CO2020016080A CO2020016080A2 CO 2020016080 A2 CO2020016080 A2 CO 2020016080A2 CO 2020016080 A CO2020016080 A CO 2020016080A CO 2020016080 A2 CO2020016080 A2 CO 2020016080A2
Authority
CO
Colombia
Prior art keywords
compounds
formula
hydrogen
treatment
methods
Prior art date
Application number
CONC2020/0016080A
Other languages
English (en)
Spanish (es)
Inventor
Pamela Brown
Michael Dawson
Mona Simonovic
Steven Boakes
Esther Duperchy
Dean Rivers
Roy Lester
Scott Coleman
Original Assignee
Spero Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spero Therapeutics Inc filed Critical Spero Therapeutics Inc
Publication of CO2020016080A2 publication Critical patent/CO2020016080A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CONC2020/0016080A 2018-06-25 2020-12-22 Compuestos CO2020016080A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862689602P 2018-06-25 2018-06-25
PCT/EP2019/066819 WO2020002325A1 (en) 2018-06-25 2019-06-25 Compounds

Publications (1)

Publication Number Publication Date
CO2020016080A2 true CO2020016080A2 (es) 2021-01-18

Family

ID=67107423

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2020/0016080A CO2020016080A2 (es) 2018-06-25 2020-12-22 Compuestos

Country Status (31)

Country Link
US (3) US11459357B2 (https=)
EP (2) EP4316504A3 (https=)
JP (2) JP7488774B2 (https=)
KR (1) KR20210054500A (https=)
CN (2) CN112789287B (https=)
AR (1) AR116663A1 (https=)
AU (2) AU2019294261B2 (https=)
BR (1) BR112020026663A2 (https=)
CA (1) CA3103158A1 (https=)
CO (1) CO2020016080A2 (https=)
DK (1) DK3810633T3 (https=)
EA (1) EA202092819A1 (https=)
ES (1) ES2971732T3 (https=)
FI (1) FI3810633T3 (https=)
HR (1) HRP20240028T1 (https=)
HU (1) HUE065134T2 (https=)
IL (2) IL279620B2 (https=)
LT (1) LT3810633T (https=)
MA (1) MA52946B1 (https=)
MD (1) MD3810633T2 (https=)
MX (1) MX2020013811A (https=)
PH (1) PH12020552240A1 (https=)
PL (1) PL3810633T3 (https=)
PT (1) PT3810633T (https=)
RS (1) RS65128B1 (https=)
SG (1) SG11202012747VA (https=)
SI (1) SI3810633T1 (https=)
TW (2) TWI851584B (https=)
UA (1) UA128162C2 (https=)
WO (1) WO2020002325A1 (https=)
ZA (1) ZA202301937B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12146004B2 (en) 2014-11-26 2024-11-19 Spero Therapeutics, Inc. Polymyxin compounds and uses thereof
RS65128B1 (sr) * 2018-06-25 2024-02-29 Spero Therapeutics Inc Jedinjenja
WO2022098950A1 (en) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Compounds
WO2022262823A1 (zh) * 2021-06-18 2022-12-22 华南理工大学 活性氧自由基响应的多粘菌素前药化合物及其应用
CN121426894A (zh) * 2025-07-24 2026-01-30 中国药科大学 一种抗菌肽、药物组合物及应用
CN120699105B (zh) * 2025-08-19 2025-11-21 中国药科大学 一种氘代抗菌肽及其组合物和应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
AU7753787A (en) 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (https=) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
CA2540742A1 (en) 2003-09-30 2005-04-14 Terry Hicks Compositions and methods for treating burns
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
BRPI0715095B8 (pt) 2006-08-11 2021-05-25 Northern Antibiotics Oy derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i).
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
CA2747995A1 (en) 2008-12-23 2010-07-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CA2855916A1 (en) 2011-11-18 2013-05-23 Novacta Biosystems Limited Polymyxin derivatives
KR102354902B1 (ko) 2013-05-22 2022-01-24 에버레스트 메디신즈 (싱가포르) 피티이. 리미티드 폴리믹신 유도체 및 상이한 항생제와의 조합 요법에 있어서의 이들의 용도
MX359104B (es) 2014-03-11 2018-09-14 New Pharma Licence Holdings Ltd Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
JP2017512818A (ja) 2014-04-01 2017-05-25 モナシュ、ユニバーシティＭｏｎａｓｈ Ｕｎｉｖｅｒｓｉｔｙ 抗菌性化合物としてのポリミキシン誘導体
US12146004B2 (en) 2014-11-26 2024-11-19 Spero Therapeutics, Inc. Polymyxin compounds and uses thereof
SG11201704627XA (en) * 2014-12-17 2017-07-28 Hoffmann La Roche Enzymatic one-pot reaction for double polypeptide conjugation in a single step using sortase
WO2016166103A1 (en) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
EP3356387B1 (en) * 2015-09-29 2024-06-26 Monash University Antimicrobial polymyxin derivative compounds
US10428122B2 (en) * 2016-06-16 2019-10-01 International Aids Vaccine Initiative, Inc. Tuberculosis compositions and methods of treating or preventing tuberculosis
RS65128B1 (sr) * 2018-06-25 2024-02-29 Spero Therapeutics Inc Jedinjenja
WO2020014501A1 (en) 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections

Also Published As

Publication number Publication date
EP4316504A2 (en) 2024-02-07
JP2024109664A (ja) 2024-08-14
FI3810633T3 (fi) 2024-02-09
SG11202012747VA (en) 2021-01-28
IL279620B1 (en) 2025-11-01
US20260103491A1 (en) 2026-04-16
PT3810633T (pt) 2024-02-19
TW202019949A (zh) 2020-06-01
ZA202301937B (en) 2023-09-27
ES2971732T3 (es) 2024-06-06
JP7488774B2 (ja) 2024-05-22
MD3810633T2 (ro) 2024-05-31
CN112789287A (zh) 2021-05-11
US20230012121A1 (en) 2023-01-12
EP4316504A3 (en) 2024-04-17
IL279620B2 (en) 2026-03-01
KR20210054500A (ko) 2021-05-13
DK3810633T3 (da) 2024-01-15
EA202092819A1 (ru) 2021-05-21
SI3810633T1 (sl) 2024-04-30
EP3810633A1 (en) 2021-04-28
IL323560A (en) 2025-11-01
CN112789287B (zh) 2024-06-21
US12528837B2 (en) 2026-01-20
PL3810633T3 (pl) 2024-04-08
MX2020013811A (es) 2021-03-09
RS65128B1 (sr) 2024-02-29
US20210246169A1 (en) 2021-08-12
AR116663A1 (es) 2021-06-02
JP2021528449A (ja) 2021-10-21
MA52946A (fr) 2021-04-28
HRP20240028T1 (hr) 2024-03-29
MA52946B1 (fr) 2024-03-29
CA3103158A1 (en) 2020-01-02
AU2019294261B2 (en) 2024-02-29
US11459357B2 (en) 2022-10-04
TWI851584B (zh) 2024-08-11
HUE065134T2 (hu) 2024-05-28
AU2024203362A1 (en) 2024-06-06
LT3810633T (lt) 2024-01-10
UA128162C2 (uk) 2024-04-24
CN118878638A (zh) 2024-11-01
TW202446783A (zh) 2024-12-01
PH12020552240A1 (en) 2021-08-16
WO2020002325A1 (en) 2020-01-02
AU2019294261A1 (en) 2021-02-04
BR112020026663A2 (pt) 2021-03-23
IL279620A (en) 2021-03-01
EP3810633B1 (en) 2023-12-13
NZ771833A (en) 2024-09-27

Similar Documents

Publication Publication Date Title
CO2020016080A2 (es) Compuestos
ECSP20021913A (es) Moduladores de la proteína reguladora de conductancia transmembrana de la fibrosis quística y métodos de uso
MX2020007485A (es) Compuestos antiproliferativos y metodos de uso de los mismos.
MX2022012313A (es) Oxisteroles y metodos de uso de los mismos.
SV2019005836A (es) Inhibidores de piridopirimdinona cdk2/4/6.
DOP2018000226A (es) Nuevos derivados de pirazolopirimidina
DOP2019000140A (es) Compuestos de heterociclo tetracíclicos útiles como inhibidores de la integrasa del vih
CO2017009891A2 (es) Inhibidores de inhibidores del factor beta de crecimiento de transformación (tgf-beta)
CO2019009373A2 (es) Compuestos heterocíclicos útiles como inhibidores duales de atx/ca.
BR112015023397A2 (pt) benzoxazois substituídos e métodos de uso dos mesmos
CO7160015A2 (es) Benzamidas n-sustituidas y su uso en el tratamiento del dolor
UY35617A (es) Inhibidores de la fosfatidilinositol 3-quinasa
BR112015022488A2 (pt) triazolopiridinas substituídas e métodos de uso das mesmas
UY32462A (es) Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644
MX2016015248A (es) Compuestos imidazo[1,2-a]pirazin-1-il-benzamida para tratar atrofia muscular espinal.
ECSP12012161A (es) Compuestos en calidad de antagonistas de Bradiquinina-b1
MX2019003724A (es) Oxisteroles sustituidos en c7 y metodos de uso de los mismos.
ECSP17069696A (es) Compuestos novedosos
CR20170496A (es) Nuevos compuestos y derivados de sulfonimidoilpurinona para el tratamiento y profilaxis de infecciones víricas
CO2020004977A2 (es) Compuestos bicíclicos para su uso como inhibidores de la ripi quinasa
CR20200002A (es) Compuestos de cetonas bicíclicas y métodos de uso de los mismos
GT201400167A (es) Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2
CO2021013166A2 (es) Compuestos de hexahidro-1h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria
CR20190236A (es) Compuestos terapéuticos y métodos para utilizarlos
AR090376A1 (es) Compuestos herbicidas